
Brazil’s Sau Paulo could roll out China’s Covid-19 vaccine without approval
Sao Paulo could roll out a COVID-19 vaccine developed by China’s Sinovac without approval from the national health regulator, Governor Joao Doria said in an interview on Thursday, pressuring Brasilia to greenlight the vaccine.
Health experts said Doria’s comments were an empty threat, as no drugs or vaccines can be used legally in Brazil without clearance from health regulator Anvisa, which pushed back against the comments. Still, his statements reveal growing tensions over the vaccine rollout in Latin America’s biggest country, with the world’s second-highest COVID-19 death toll.
Critics of President Jair Bolsonaro argue he is threatening the independence of Anvisa with political appointees to gain leverage over governors and other rivals.
In a video interview on the news website Metropoles, Doria said Sao Paulo could use the vaccine from Sinovac Biotech Ltd based on approval from regulators in other countries.
“Today, there is suspicion that Anvisa could suffer political interference from the presidency and could fail to be an independent agency as it should be, as it must be,” he said.
He added the state would consider the vaccine appropriate for use if approved by authorities “in the United States, in Europe and, above all, in Asia.”
In a statement, Anvisa said that was impossible.
“It is important to clarify that the tacit approval of vaccines by other agencies ... is not foreseen in the law,” the regulator said. “Even after it is approved in another country, Anvisa’s approval is necessary.”
Doria, a staunch opponent of Bolsonaro, has already ordered the construction of facilities to produce the Sinovac vaccine, which is currently undergoing late-stage trials in Sao Paulo and elsewhere in Brazil.
Bolsonaro, a strident China critic, has frequently dismissed the Sinovac vaccine, known as Coronavac, saying he is concerned about its “origin.”
So far, the federal government’s principal bet has been on a vaccine being developed by AstraZeneca, though federal health officials have also held discussions with other vaccine developers, such as Johnson & Johnson and Pfizer Ltd . (Reporting by Eduardo Simões Writing by Gram Slatteryand Gabriel Stargardter Editing by Brad Haynes, Tom Brown and Aurora Ellis)

Joe Biden to unveil Covid plan on first full day in office

Angry China sanctions Pompeo, 27 Trump officials during Biden oath

On day one, Biden takes US back to Paris climate accord, World Health Organization

Indian-American lawmakers say Biden, Harris will heal America

Avril Haines is first official member of President Joe Biden's cabinet

Taiwan's 'de-facto' ambassador to US attends Joe Biden's inauguration

China to impose virus testing on Lunar New Year travellers, cases rising

Biden bets big on immigration changes in opening move

Pak election commission issues notices to 19 political parties

US to re-enter Paris Agreement: All you need to know about climate accord

Immigrants feel positive about reforms to immigration rules under Biden
- Biden also issued executive orders reversing some of former President Donald Trump's immigration policies, such as halting work on a US-Mexico border wall and lifting a travel ban on people from several predominantly Muslim countries.

Trump Discloses $40,000 in Gifts Received During Final Year

Biden signs order to end Trump's Muslim travel ban

Biden's first foreign leader call will be to Canadian PM Trudeau: White House
